Tokyo, Jan. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060314) titled 'Effect of a communication support device on cognitive function testing in patients with hearing loss' on Jan. 10.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - No treatment
Primary Sponsor:
Institute - National Center for Geriatrics and Gerontology
Condition:
Condition - inpatients
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effect of using a communication support device for Mini-Mental State Examination in patients with hearing loss
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - MMSE-J, VAS, and RCPM test with a communication support device.
Interventions/Control_2 - MMSE-J, VAS, and RCPM test without a communication support device.
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who were able to perform the cognitive function testing.
Patients who could sit on a chair during testing.
Key exclusion criteria - Patients who are unable to follow the therapists' instructions adequately.
Patients who are expected to be discharged within two weeks.
Patients who were discharged or transferred to another ward due to sudden deterioration before the final evaluation.
Target Size - 115
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2024 Year 10 Month 10 Day
Date of IRB - 2024 Year 10 Month 10 Day
Anticipated trial start date - 2024 Year 10 Month 10 Day
Last follow-up date - 2026 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068996
Disclaimer: Curated by HT Syndication.
